Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.
Eunsol YangSang Chun JiIn-Jin JangSeung Hwan LeePublished in: Clinical pharmacokinetics (2023)
Clinicaltrials.gov identifier: NCT04568772 (Registered on September 29, 2020).